Skip to content

Efficacy of acupuncture in patients with gastroesophageal reflux disease: a randomized controlled pilot trial

Efficacy of acupuncture in patients with gastroesophageal reflux disease: a randomized controlled pilot trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076622
Enrollment
Unknown
Registered
2023-10-13
Start date
2023-10-14
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastroesophageal reflux disease

Interventions

Conventional acupoints group:Acupuncture on conventional acupoints
Du meridian acupoints group:Acupuncture on Du meridian acupoints
Sham acupuncture group:Sham acupuncture

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: ? Older than 18 years ? Patients with partial remission of reflux symptoms after receiving standard doses of PPI and/or patients with erosive esophagitis indicated by esophagoscopy and/or 24h esophageal PH-impedance monitoring suggested the presence of gastroesophageal reflux disease ? Patients did not change their GERD treatment regimen within 30 days (including no medication or no change in medication use within 30 days) ? Typical gastroesophageal reflux symptoms (regurgitation, heartburn) have been present for at least 2 days per week for the past 3 months ? Hiatal hernia= 2cm ? Understand and sign the informed consent form

Exclusion criteria

Exclusion criteria: ?Active severe erosive esophagitis (Los Angeles C or D) ?Barrett's Esophagus ?Combined with digestive ulcer, suspected or confirmed malignant tumor, or other warning symptoms ?history of gastric or oesophageal surgery ?Esophageal motility disorders, eosinophilic esophagitis, digestive tract obstruction, ischemic heart disease ?Serious abnormalities of heart, liver, kidney function, hematopoietic system, mental illness or other serious co-existing diseases ?Women who are pregnant, lactating, or planning to become pregnant during the trial ?Received acupuncture treatment for gastroesophageal reflux within the past 6 months ?Participate in other clinical studies within 1 month

Design outcomes

Primary

MeasureTime frame
The response rate;

Secondary

MeasureTime frame
The response rate;The Gastroesophageal Reflux Disease-Health Related Quality of Life;Reflux Disease Diagnostic Questionnaire;Los Angeles type of reflux esophagitis;The Gastrointestinal Symptom Rating Scale;Short Form Health Survey 12;Hospital Anxiety and Depression Scale;Pittsburgh sleep quality index;Global perceived recovery;Blinding assessment;Credibility assessment;The use of rescue medicine or other treatment methods;Adverse event rate;

Countries

China

Contacts

Public ContactCunzhi Liu

School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine

lcz_tg@126.com+86 10 5391 2201

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026